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AD-MSC - adipose tissue-derived mesenchymal stem cell 
ALP - alkaline phosphatase  
BM-MSC - bone marrow-derived mesenchymal stem cell  
CEMP1 - cementum protein 1  
CFU-F - colony forming unit-fibroblast 
DCV - DyeCycle Violet  
HUES - human embryonic stem cell 
MSC - mesenchymal stem cell 
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OSX - osterix  
PDL - periodontal ligament 
PDLSC - periodontal ligament stem cell 
PPARγ - peroxisome proliferator-activated receptor gamma  
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Abstract 
 
Periodontal ligament stem cells (PDLSC) provide an important source for tissue 
regeneration and may become especially useful in the formation of osteogenic seeds. PDLSCs 
can be cultured, expanded and differentiated in vitro, thus may be applied in the long-term 
treatment of the defects in the dental regions. Here we studied numerous potential markers 
allowing the selection of human PDLSCs with a maximum differentiation potential. We 
followed the expression of the ABCG2 membrane transporter protein and isolated ABCG2-
expressing cells by using a monoclonal antibody, recognizing the transporter at the cell 
surface in intact cells. The expression of the ABCG2 protein, corresponding to the so called 
side population (SP) phenotype in various tissue-derived stem cells, was found to be a useful 
marker for the selection of PDLSCs with enhanced osteogenic, chondrogenic and adipogenic 
differentiation. These findings may have important applications in achieving efficient dental 
tissue regeneration by using stem cells from extracted teeth.     
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Introduction 
 
The periodontal ligament (PDL) is a soft connective tissue with a physiological role to fix 
the tooth into the alveolus. In addition to its anchoring function, this tissue has an important 
role in the homeostasis and regeneration of the periodontium [1, 2], which is critical in the 
cases of tooth loss, chronic periodontitis or deep intraosseous defects [3, 4]. There is a 
continuous clinical need to find cellular therapies for the regeneration of the attachment 
apparatus that is destroyed as a result of periodontitis. Periodontal regeneration requires new 
connective tissue attachment to the root surface, a process that involves the regeneration of 
periodontal fibers and the insertion of these fibers into newly formed cementum [5].  
The surgically removed wisdom teeth may provide a large number of cells that can be 
easily isolated from the tooth surface and expanded in in vitro cultures. The periodontal 
ligament contains heterogeneous cell populations, predominantly fibroblasts and a small 
subset of cells with self-renewing and clonogenic ability. These latter cells are called 
periodontal ligament stem cells (PDLSC). These progenitor cells are capable of differentiating 
both into osteoblasts, cementoblasts or fibroblasts, and produce the extracellular matrix of the 
periodontal ligament [6, 7]. According to the data in the literature, the osteoblastic and 
cementoblastic phenotype is based on the expression of alkaline phosphatase (ALP), 
osteopontin (OPN), osteocalcin (OCN), osterix (OSX) and cementum protein 1 (CEMP1) [7-
9]. Cells derived from PDL also possess of mesenchymal stem cell (MSC) like features, that 
is in vitro osteogenic, adipogenic and chondrogenic differentiation potential, the expression of 
MSC markers (STRO-1, CD13, CD29, CD44, CD73, CD90, CD105 and CD166), and the 
lack of expression of hematopoietic markers.  
Although there were several attempts to find a unique cell surface marker (CD106, 
CD146, SSEA4, STRO-1) [10-12] to identify a subset of PDL cell population with enhanced 
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multilineage differentiation capacity, these efforts were unsuccessful to candidate for 
regenerative therapy application as yet. 
A potential approach to identify such multipotent tissue-derived stem cells is to look for 
the so called side-population (SP) cells. These cells have been identified based on their low-
level staining by the Hoechst 33342 fluorescent dye, due to the active dye extrusion by the 
ABCG2 protein, expressed at a higher level in these cells [13]. During the past few years SP 
cells were identified in numerous normal and cancerous tissues, representing early progenitors 
or stem cells [14-16]. It has been shown that the periodontal ligament also contains an 
ABCG2-expressing side population [17] but functional data for the differentiation of these SP 
cells have not been reported as yet. Ninomiya et al [18] suggested an elevated bone 
differentiation capacity for rat PDLSC showing SP features, although in this case the dye 
extrusion was ABCB1-dependent.  
Based on these studies, the selection of human PDLSC expressing ABCG2 may help to 
identify a multipotent stem cell population for therapeutic applications. It is important to note, 
that a selection based on the use of DNA-binding dyes, potentially causing major genetic 
alterations, does not allow a further clinical utilization of these cells. Therefore, we have used 
a specific antibody-based sorting method to enrich ABCG2-expressing SP cells, applicable 
for stem cell based therapy, without the use of potentially toxic fluorescent dyes. Here we 
demonstrate the successful sorting and detailed characterization of these cells, and the 
relationship between ABCG2 expression and an increased bone forming ability of the selected 
PDLSCs.  
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Materials and Methods 
 
Cell isolation and culture 
Work with human PDLSCs was performed with the permission of the Ethical Committee 
of the Hungarian Medical Research Council (ETT). The donors gave written permission for 
the utilization of the removed tissues. We have isolated and characterized several samples 
(n=7) from different donors (aged 17-35) with variable ABCG2 expression. 
Most of the reagents were purchased from Life Technologies Japan Ltd. (Tokyo, Japan), all 
others as indicated. The teeth were rinsed in phosphate-buffered saline (PBS) and scraped 
with scalpel. Enzymatic digestion was performed with 0.1% w/v collagenase type I (Sigma-
Aldrich, St. Louis, MO, USA) at 37°C for 1 hour. Digestion was stopped by adding identical 
volume of MSC expansion medium (D-MEM/F-12, 10% v/v fetal bovine serum (FBS), 1 
ng/ml FGF-2). The digested cell suspension was centrifuged at 800 g for 10 minutes, washed 
with PBS, and resuspended in MSC expansion medium. Initially, cells were plated at a 
density of 2x10
5
/cm
2
. Following selection for plastic adherence, PDLSCs were subcultured 
once a week at a density of 4x10
3
/cm
2
.  
Human embryonic stem cell line 9 (HUES9) was a kind gift of Douglas Melton, Harvard 
University, USA. The HUES culture conditions were used as described in detail by Apáti et al 
[19]. 
 
Flow cytometry 
Expression of the cell surface markers was assessed by flow cytometry, as described 
previously [20]. All antibodies were purchased from BD Biosciences (Erembodegem, 
Belgium).  In the case of using unlabeled primary antibodies (ABCG2, ALP, HLA-G), the 
cells were subsequentially stained with fluorescent-conjugated isotype matched secondary 
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goat anti-mouse antibodies with shaking in a 37°C water bath. For maximum cell surface 
labeling of ABCG2 with the conformation sensitive 5D3 monoclonal (IgG2b) antibody, the 
specific ABCG2 inhibitor, Ko143 (Sigma-Aldrich) was added. 7-Amino-actinomycin D (7-
AAD) or TO-PRO-3 iodide was used for the exclusion of dead cells. All control cells were 
stained with the corresponding isotype controls. The measurements were done in a 4-color 
FACSCalibur flow cytometer (BD Biosciences), data were analyzed with CellQuest Pro 
software (BD Biosciences). For cell sorting 1x10
6
 cells were labeled with the anti ABCG2 
antibody as described above. Cell surface located ABCG2 positive and negative cells were 
analyzed and sorted by using FACSAria flow cytometer (BD Biosciences). 
 For DyeCycle Violet (DCV) staining, the cells were incubated with 2 µM DCV for 30 
minutes with shaking in a 37°C water bath. To inhibit ABC transporters, 5 µM Ko143 
(Sigma-Aldrich) or 10 µM verapamil (Sigma-Aldrich) was added. DCV was excited at 405 
nm by ultraviolet laser and its dual wavelengths were detected using 450/40 (DCV-Blue) and 
603/48 (DCV-Red) filters in an Attune Acoustic Focusing Cytometer (Life Technologies).  
 
STRO-1 immunohistochemistry 
Cells were fixed with 4% w/v paraformaldehyde, blocked against nonspecific staining 
with 1% w/v BSA and 4% v/v nonimmune serum, and incubated with primary mouse anti-
STRO-1 monoclonal antibody or mouse IgM isotype control for 1 hour at room temperature. 
AlexaFluor 546 secondary antibody were applied for fluorescent detection, and nuclei were 
counterstained with DAPI. 
 
Cell proliferation 
Proliferation of different PDLSC isolates was compared using a cellular viability assay, 
based on the reduction of the nonfluorescent resazurin (Sigma-Aldrich) dye to fluorescent 
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resorufin. Cells were seeded in growth medium at a density of 500/cm
2
 in 96-well 
microplates. At each time point (from day 1 to 7), one microplate was measured as described 
previously [20]. 
 
Colony forming unit-fibroblast assay (CFU-F) 
To assess the colony-forming efficiency of PDLSC samples, cells were seeded at a density 
of 400 cells/10 cm culture dishes in MSC growth medium. After 14 days, the cells were fixed 
with 4% w/v paraformaldehyde and stained with 0.04% v/v crystal violet. Aggregates of 50 or 
more cells were scored as a colony-forming unit-fibroblast (CFU-F) colonies. Colony-forming 
efficiency was determined by the number of colonies relative to the total number of seeded 
cells in each plate. 
  
Osteogenic, chondrogenic and adipogenic differentiation 
For osteogenic differentiation the cells were kept in an osteogenic medium (StemPro 
Osteogenesis Differentiation Kit). After 7 days of induction, differentiated and 
undifferentiated samples were collected to test alkaline phosphatase activity. Following cell 
lysis with 0.1% w/v Triton X-100 solution diluted in ALP buffer (50 mM TRIS, 150 mM 
NaCl, 10 mM MgCl2, pH 9.5) the enzyme activity was detected with p-nitrophenyl phosphate 
(pNPP) in final concentration of 50 mM dissolved in ALP buffer. After 1 hour of incubation 
at room temperature the supernatants were transferred to a 96-well plate and fluorescence was 
read at 405 nm in a plate reader (Perkin-Elmer, Waltham, MA, USA). The data were 
normalized based on total protein concentrations determined with the Lowry method.  
After 14 days the cells were fixed and stained with 2% w/v Alizarin red at pH 4.2. To 
quantify the mineralization, the stain was dissolved with a solution containing 10% acetic acid 
and 20% methanol. Fluorescence was read at 450 nm in a plate reader. Calcium deposition 
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was also measured with Calcium (CPC) LiquiColor Test (Stanbio Laboratory, Boerne, TX, 
USA), according to the manufacturer’s instructions.  
For chondrogenic differentiation 2x10
5
 PDLS cells were plated in 5 µl culture medium in 
a 24 well cell culture dish for 1 hour, then chondrogenic medium (StemPro Chondrogenesis 
Differentiation Kit) was added, and changed twice a week for 14 days. For histological 
examination, the pellets were fixed in 4% paraformaldehyde, embedded in paraffin and cut 
into 5 µm sections. Newly synthesized glycosaminoglycans were evaluated by hematoxylin 
and eosin staining, following deparaffinization. 
For adipogenic differentiation the cells were kept in an adipogenic medium (StemPro 
Adipogenesis Differentiation Kit) for 14 days, than fixed and stained with Oil Red O. To 
quantify the lipid accumulation, the stain was dissolved with 100% isopropanol, the 
fluorescence was read at 490 nm. 
 
Gene expression analysis 
Total RNA was isolated from undifferentiated and differentiated cells and cDNA was 
synthesized as previously described [20]. The expression levels of OCT4, SOX2, NANOG, 
ALP, ABCG2, CEMP1 and the peroxisome proliferator-activated receptor gamma (PPARγ) 
gene known as an adipocyte marker were measured using TaqMan reagents. The expression 
of OCN, OSX and SOX9 mRNA was determined by using Power SYBR Green reagents in 
StepOne Plus qPCR instruments (Life Technologies). The list of primers and assays shown in 
Supplemental Table 1. 
 
 Statistical analysis 
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Gene expression levels were calculated with 2
(-ΔCt)
 method relative to GAPDH as a reference. 
The data are presented as the mean ± SD. Student’s t-test was used for the comparison of the 
sorted cell populations. 
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Results 
  
Characterization of PDLSC isolates 
The cells isolated from periodontal ligament as described in the Methods section are most 
probably close relatives of the mesenchymal stem cells (MSCs), with variable differentiation 
potential in different tissues. In order to establish these features we performed a detailed 
characterization of these cells. The basic characterization of the cell surface markers was 
performed by quantitative flow cytometry.   
As shown in Supplemental Table 2, in accordance with the data in the literature, we found 
that all PDLSC isolates expressed in 100% the general MSC cell surface markers (CD13, 
CD29, CD44, CD73, CD90 and CD105). The endothelial progenitor marker CD146 (MCAM, 
MUC18), was expressed in a highly variable proportions (4-62%), and the CD106 protein 
(VCAM-1), again an endothelial progenitor marker, was expressed in 0-48% on the cell 
surface of the cultured PDLSCs. All the markers identifying hematopoietic or endothelial cell 
types (CD14, CD34, CD45, CD117, CD133, CD31, CD144 and CD309) were practically 
absent, or expressed at a low level (HLA-DR).   
The potential mesenchymal stem cell marker STRO-1 was also measured on the surface of 
cells by flow cytometry, and was found in less than 1% in all PDLSC isolates (Supplemental 
Table 2). Immunohistochemical staining of STRO-1 was also performed, in order to confirm 
the flow cytometry measurements (Supplemental Figure 2A, B). 
To examine the presence of potential multipotent/pluripotent stem cells in the 
preparations, we investigated the expression of a glycolipid, the stage-specific embryonic 
antigen-4 (SSEA4) marker on the cell surface, as well as the expression of mRNA for OCT4, 
NANOG, and SOX2 in the cell populations. We found that only a low percentage  (0-7%) of 
PDLSCs expressed the SSEA4 marker, and the mRNA levels for the pluripotency markers 
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were neglible (ΔCT values were 6.68-10.01), as compared to the embryonic stem cell line 
HUES9 (ΔCT values 0.68-2.93) – see Supplemental Figure 1. 
The ABCG2 (MXR/BCRP) multidrug transporter has been indicated to provide a marker 
for tissue-derived stem cells, corresponding to the side-population (SP) fraction. The SP cells 
show a low-level Hoechst or DCV dye accumulation, due to the dye transport activity of 
ABCG2, which can be inhibited by blocking ABCG2 function e.g. by verapamil, FTC, or 
Ko143. The ABCG2 protein, although in variable proportions, has also been shown to be 
present in human embryonic stem cells and induced pluripotent stem cells [21, 22]. Therefore 
we examined the functional presence of the ABCG2 protein in PDLSCs by measuring DCV 
dye „side-populations”, and the cell surface ABCG2 expression by using a monoclonal 
antibody (5D3), recognizing this protein on the cell surface. Since the 5D3 mAb is a 
conformation-sensitive antibody [23], we assured maximum labeling in these experiments 
(see Methods).   
As shown in Figure 1, PDLSC isolates showed variable expression levels for the ABCG2 
transporter. By using the DCV extrusion (SP detection) method, we found that the SP fraction 
varied between about 1-17% of the cells, while the 5D3 method indicated a higher fraction of 
the ABCG2 positive cells, approximately between 2-64% positivity, depending on the actual 
source of isolation. The mRNA expression levels for the ABCG2 transporter, measured by 
qPCR, also showed variable levels, although consistent with the protein expression pattern for 
each isolate. As a summary, based on all assays, the F38 and F28 isolates had a significantly 
higher ABCG2 mRNA and protein expression than the other isolates. All these marker and 
mRNA expression patterns were well reproducible for an extended time period (15 passage at 
least) with moderate decrease of ABCG2 expression in the PDLSC cultures.  
 
Culturing and differentiation of the PDLSC isolates 
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When measuring the proliferation activity of the different PDLSC isolates, these were 
variable in each preparation, showing doubling times between 0.3-1.5 days. In this regard, we 
found no correlation of the cell growth with the marker expressions or with the levels of 
ABCG2 expression as estimated by flow cytometry (Supplemental Figure 3A and 3B).   
Mesenchymal stem cells have colony forming ability on plastic surfaces. All of the 
PDLSC isolates contained a subpopulation that was capable of generating colonies from 
single cells (Supplemental Figure 4A, B). However the CFU-F frequency varied between 14-
32% and no correlation was found between the ABCG2 expression level and the CFU-F 
frequency (Supplemental Figure 4C). The densities of the colonies correlated with the 
proliferation ability of the cells, which was independent from the level of ABCG2 expression. 
The differentiation potential of the PDLSCs was followed by standard induction 
protocols, measuring both osteogenic, chondrogenic and lipogenic differentiation.  
For bone differentiation, after 14 days of osteogenic induction we quantified the calcium 
deposition in the cells with alizarin red S staining (Figure 2A, B), and the Calcium Liquicolor 
test (Supplemental Figure 5). We found that the PDLSC isolates showing higher ABCG2 
expression (F38 and F28) achieved significantly higher calcium accumulation than the cell 
isolates with low level ABCG2 expression. Thus the cellular ABCG2 expression showed a 
positive correlation with the overall osteogenic differentiation potential of the PDLSC isolates 
(Figure 2C).   
The glycosaminoglycan formation was visualized with hematoxylin and eosin staining 
after 14 days of chondrogenic differentiation (Supplemental Figure 6A). No significant 
correlation between ABCG2 and SOX9 expression (a transcription factor involved in 
chondrogenesis; Supplemental Figure 6B) was noticeable in the case of the PDLSC isolates 
(Supplemental Figure 6C). 
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We have also studied the adipogenic differentiation of the the PDLSC isolates, by 
culturing these cells in adipogenic medium for 14 days and performed a quantification by oil 
red O staining (Supplemental Figure 7A, B), and by an RT-qPCR measurement of the PPARγ 
gene expression level (Supplemental Figure 7C). We found that the amount of the 
accumulated lipids and the changes in the expression level of the PPARγ gene showed a weak 
correlation with the ABCG2 expression in the various PDLSC isolates (Supplemental Figure 
7D). 
 
Isolation and characterization of ABCG2-expressing PDLSCs 
In order to further investigate the correlation between ABCG2 expression and the 
osteogenic ability of PDLS cells we sorted three PDLSC sample (namely F48, F38 and F28) 
to ABCG2
high
 and ABCG2
low
 populations (Figure 3A), by using an anti-ABCG2 antibody (see 
Methods). After cell sorting, by measuring dye extrusion, we found that the high ABCG2-
expressing cells indeed corresponded to a higher level of the SP population (Supplemental 
Figure 8A). The mRNA expression level of ABCG2 was in accordance with the flow 
cytometer measurements (Supplemental Figure 8B). The ABCG2 expression of sorted cells 
was followed for a long period (15 passage at least) and moderate decline was noticeable. 
In these sorted samples we have examined the proliferation ability, osteogenic and 
adipogenic differentiation potential of the cells. When measuring cell growth, we found that 
the sorted cell populations showed no differences in their proliferation activities 
(Supplemental Figure 9). 
For osteogenic induction, the unsorted (parental), ABCG2
high
 and ABCG2
low
 cell 
populations were cultured in an osteogenic medium for 7 days. Alkaline phosphatase (ALP) 
activity, greatly increasing during osteogenic differentiation, was significantly higher in the 
ABCG2
high 
cells, as compared to the parental or the ABCG2
low 
cell populations (Supplemental 
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Figure 10). The gene expression of ALP also strengthens these observations (Figure 3D).  As 
a key parameter of osteogenic differentiation, calcium deposition measured - after 14 days 
osteogenic induction - with alizarin red S staining, was much greater in the ABCG2
high
 cell 
populations than in the parental cells or the PDLSC that expressed low levels of ABCG2 (Fig. 
3B, C). Thus the mineralization of the sorted ABCG2
high 
PDLS cells was significantly 
accelerated.  
When measuring the gene expression for several markers of the osteogenic differentiation, 
we found a similar positive correlation with the ABCG2 expression level. As documented in 
Figure 4, the mRNA level of osteocalcin (OCN, Fig. 4A, and the transcription factor osterix 
(OSX, Fig. 4B), involved in bone matrix maturation, were also higher in the ABCG2
high 
cells 
after 7 days induction. In addition, the mRNA expression level of the cementum protein 1 
(CEMP1) gene, a marker of cementogenesis, was also higher in the ABCG2
high 
cells (Figure 
4C). 
Chondrogenic differentiation was performed on F38-parental cells and the isolated 
ABCG2
high 
and ABCG2
low
 cells. The density of newly formed glycosaminoglycans was 
significantly higher in the ABCG2
high
 cell population after 14 days of differentiation (Figure 
3E). We also found an elevated mRNA expression level for the chondrogenic transcription 
factor SOX9, in correlation with the hematoxylin and eosin staining in the cartilage pellet 
(Figure 3F). 
Under adipogenic induction of the PDLSCs, the gene expression level of PPARγ (Figure 
3I) and the lipid accumulation (quantitated in the sorted cells by oil red O staining – Figure 
3G, H) after 14 days of differentiation also showed a positive correlation with the level of 
ABCG2 expression. Thus a general effect of higher ABCG2 levels on the differentiation 
potential of PDLSCs was observed.  
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In order to examine the role of ABCG2 function in PDLSC differentiation, we used a 
specific, selective inhibitor of the ABCG2 function, Ko143. We kept a PDLSC sample (F38) 
in osteogenic medium for 14 days, complemented with the ABCG2 inhibitor Ko143 in a final 
concentration of 1 μM, shown to have a full ABCG2 inhibitory activity. When measuring the 
calcium accumulation in the cells, we found no difference between the Ko143 treated and the 
control cell (Supplemental Figure 11A). These data indicate no direct functional role of the 
ABCG2 protein in the osteogenic differentiation. Moreover, when we measured the changes 
in ABCG2 expression during osteogenic differentiation, we found a significant reduction in 
the mRNA level (Supplemental Figure 11B), and a loss of ABCG2 from the cell surface after 
7 days in osteogenic medium (see Supplemental Figure 8C for a representative sample). 
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Discussion 
 
Human periodontal ligament stem cells (PDLSCs) are easily accessible, rapidly growing 
cells, characterized by the mesenchymal cell markers, and providing promising candidates for 
cell therapy applications. In this study we have used human PDLSCs obtained from tissues 
after necessary surgeries, and characterized the isolated cells for general expression markers. 
We found that all PDLSC preparations corresponded to the minimal criteria [24] defining 
mesenchymal stem cells (MSCs). The conventional cell surface markers of MSCs were 
present on the surface of isolated cells, while the stromal cell marker STRO-1 was present 
only in a low percentage. The cells possessed clonogenic ability and a proper differentiation 
capacity in the osteogenic, chondrogenic and adipogenic direction, indicating a close 
relationship of these cells with MSCs. 
PDLSCs were reported to contain a smaller cell population (side population, SP) 
excluding the fluorescent dye Hoechst33342 [17]. This Hoechst, or the analog Vibrant 
DyeCycle Violet [25] extrusion is mediated in most cases by the ABCG2 multidrug 
transporter. The SP cells were found to possess stem cell like features in various tissues [26, 
27] including the dental follicle of rat [28], or human dental pulp [29]. Therefore in the 
present experiments we have studied the potential correlation of the ABCG2 protein 
expression profiles and differentiation potential of PDLSCs.  
In our experiments we have used two different technologies to estimate the SP cells and 
the ABCG2 protein expression in the PDLS cells. These were flow cytometry measurements, 
either using a cell surface reacting, ABCG2-specific monoclonal antibody (5D3), or the 
Vibrant dye (DCV) exclusion method. Moreover, DCV extrusion was blocked either by 
verapamil or the specific inhibitor of ABCG2, Ko143. Since the two inhibitors gave similar 
results, we suggest that in PDLSCs for most of the dye exclusion feature the activity of the 
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ABCG2 protein was responsible. In these experiments the most sensitive estimation of the 
ABCG2 positive population was obtained by the specific monoclonal antibody based flow 
cytometry detection. 
In the various PDLSC isolates we found a variable level of ABCG2 expression but we 
observed that the PDLSCs showing higher ABCG2 expression achieved significantly higher 
calcium accumulation than the cell isolates with low level ABCG2 expression. Thus, in 
general, the cellular ABCG2 expression showed a significant, positive correlation with the 
osteogenic differentiation potential of PDLSCs. 
In order to further investigate the role of ABCG2 expression in the differentiation ability 
of human periodontal tissue-derived cells, and to avoid interdonor variance in age and genetic 
background, we isolated ABCG2
high 
and ABCG2
low 
cell populations from three PDLSC line 
by using an antibody-based cell sorting. In these experiments we found that ABCG2
high 
cells, 
after an osteogenic induction, showed a significant upregulation of all examined 
osteoblastic/cementoblastic markers, as compared to the ABCG2
low 
and the parental PDLSC 
populations.  
The increased differentiation ability was not limited to the osteogenesis. Although the 
chondrogenic and adipogenic differentiation potential of isolates showed no (or only a weak) 
correlation with ABCG2 expression, following the antibody based selection of cells, in the 
case of chondrogenesis the ABCG2
high 
population showed an elevated SOX9 expression and a 
higher density of glicosaminoglycans was detectable. 
The elevation of PPARγ expression and lipid accumulation was also typical in 
ABCG2
high
 samples after 14 days of induction in adipogenic differentiation medium. It has to 
be noted that the lipogenic potential of PDLSCs is limited, and the number and size of lipid 
droplets are variable in different isolates. Furthermore, the age and genetic background of 
donors can also influence the differentiation ability of the isolates. These features may explain 
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why a significant correlation was not found in the isolates, while the sorting of the samples 
into ABCG2 high and low populations may have eliminated these differences (see Figure 3G, 
H, I). 
Our results are in accordance with the observations on human dental pulp stem cells, in 
which an enhanced in vitro osteogenic, adipogenic, neurogenic and endothelial differentiation 
ability was detected in the ABCG2-expressing SP cells, as compared to the main population 
[29]. These data indicate that SP cells in the dental region may possess multilineage potential. 
Our simple, antibody-based selection method of cells enriched in ABCG2 may be a 
proper basis for studies determining the potentially increased in vivo osteogenic/cementogenic 
potential ABCG2
high
 PDLSCs.  The bone/cementum forming ability of PDLSCs has been 
already confirmed in an ectopic mouse model [30], rat periodontal fenestration defect model 
by using allogenic PDLSCs [31], in a combined sheep-mouse xenogenic model [32], and in a 
canine model [33]. In humans the therapeutic application of PDLSCs has been suggested to be 
safe, as a successful pilot study has been performed with three human patients suffering from 
periodontitis. In these patients autologous periodontal ligament cell transplantation has been 
performed [34]. 
A limitation in clinical applications is the available cell number for transplantation. The 
self-renewing ability of PDLSCs and the fact they can be kept in culture for long periods of 
time without phenotypical changes, allow potential clinical applications. Furthermore, these 
cells can be isolated from cryopreserved periodontal ligaments, thus providing a ready source 
of MSCs [35]. As a most promising subpopulation of PDLSCs for potential therapy, with an 
enhanced multilineage differentiation capacity, was suggested the population of 
CD146+/STRO-1+ cells, comprising about 2-3% of the PDLSCs [6, 36]. In contrast, ABCG2 
expression, as found in this study, occurs in a much greater PDLSC population, allowing the 
selection of a higher number of cells for efficient therapeutic applications. 
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A key question was in these experiments if ABCG2 provides only a cellular marker for 
an increased differentiation capacity of PDLSCs, or the function of this protein (potentially 
exporting endo- and xenobiotics from the cells) is also an important factor. Our present 
experiments argue against such a functional role as ABCG2 expression was significantly 
down-regulated in the early stages of the differentiation process. Moreover, the selective 
inhibition of the ABCG2 function by a high-affinity inhibitor, Ko143, had no measurable 
effect on the osteogenic differentiation of PDLSCs.  
In parallel experiments, not detailed here, we also investigated the presence of ABCG2 
transporter in mesenchymal stem cell isolates derived from bone marrow (BM-MSC) and 
adipose tissue (AD-MSC), and negligible ABCG2 expression was detectable at mRNA as 
well as at protein level. However, the osteogenic differentiation capacity of these cells was 
commensurable with the bone forming activity of PDLSCs (data not shown). Based on these 
observations we suggest that ABCG2, although serves as a marker for differentiation in 
PDLSCs, has no functional role in the process of bone differentiation.  
Mesenchymal stem cells in the craniofacial region are derived from neural crest, in 
contrast to other skeletal MSCs (like BM-MSC and AD-MSC) which develop from the 
mesoderm [37, 38]. High ABCG2 expression has already been described in other neural crest 
derived MSC populations, isolated from dental pulp [29], and corneal stroma [39]. Therefore 
it is possible that ABCG2 expression represents a progenitor cell marker in the neural crest 
derived craniofacial region, although further investigations are necessary to strengthen this 
hypothesis. 
As a conclusion, we found that ABCG2 expression in PDLSCs shows close correlation 
with their osteogenic, and in general, their differentiation capacity. Moreover, a non-invasive 
sorting of ABCG2-expressing PDLSCs may be a suitable tool to enrich cells with increased 
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osteogenic and/or cementogenic capacity from the periodontal ligament for clinical 
applications in the future. 
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